Follow the Kopran Limited stock price and the full directors' dealings record of the company, a listed issuer based in India. Shares are listed on the IN market, under the oversight of SEBI (PIT + SAST). Operating in the Health Care sector, Kopran Limited has recorded 8 public disclosures. Market capitalisation: €9.2bn. The latest transaction was filed on 8 January 2025 (Purchase). Among the most active insiders: Mridula Somani. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
8 of 8 declarations
Kopran Limited is a company operating in the healthcare and pharmaceutical sector, specializing in the manufacture of pharmaceutical products. It is listed on the XBOM.